Separation of plasminogen activators from human uterine tissue and a comparison with activators from human urine and porcine tissue.
Three types of plasminogen activator could be distinguished in extracts from human uterine tissue. The activators differed in thermostability or in mode of inhibition by EACA. All the extracts contained stable as well as labile activators. The saline extracts were uniformly inhibited by increasing concentrations of EACA. Extracts made with 2 M ammonium thiocyanate were either uniformly inhibited by EACA or showed deflections indicating contamination with an activator, which was inhibited in a biphasic manner. It was possible to distinguish between: (1) An activator, abundantly present in the tissue, which was uniformly inhibited and stable. (2) Another uniformly inhibited activator, which was labile. (3) An activator, inhibited in a biphasic manner, similar to urokinase, which was present in varying amounts in uteri with the endometrium in the proliferative phase. Gel filtration of the uterine extracts showed two major activity peaks corresponding to particle sizes of 60,000 dalton and about 10,000 dalton. Antiserum to purified plasminogen activator, prepared from porcine ovaries, inhibited the activity of the human uterine extracts, but not the activities of human urokinase or urine. Urokinase antiserum in a concentration completely inhibiting human urine or urokinase, inhibited only 10% or less of the activities of human uterine extracts.
D015119:Aminocaproic Acid / Q000494:pharmacology; D000818:Animals; D005260:Female; D005337:Fibrin; D006801:Humans; D010960:Plasminogen Activators / Q000037:antagonists & inhibitors / Q000302:isolation & purification* / Q000652:urine; D015849:Plasminogen Inactivators; D013552:Swine; D014599:Uterus / Q000032:analysis*
D015849:Plasminogen Inactivators; D005337:Fibrin; D010960:Plasminogen Activators; D015119:Aminocaproic Acid